TOP

A 2023 Calendar for China's Reopening and Recovery

Andy Rothman gives his insight on how China may live with COVID in the months ahead.

  • 01/10/2023
Subscribe

China’s leaders continue to take steps designed to remove obstacles to daily life and to support economic growth. Investment Strategist Andy Rothman shares his 2023 monthly outlook on how China’s reopening and economic recovery might play out. This calendar offers his monthly base case, as well as the key risks for China’s reopening.

*As of November 30, 2022, accounts managed by Matthews Asia portfolios held positions in Taiwan Semiconductor Manufacturing Company.

8-for-2023logoCTA.jpg

Featured Funds

MCH

China Active ETF

High-conviction equity portfolio seeks companies benefiting from China’s domestic consumption. All-cap fundamental GARP approach driven by on-the-ground research.

MCSMX

China Small Companies Fund

The Fund focuses on innovative, efficient and sustainable growth companies, with an emphasis on businesses oriented toward domestic demand and rising income levels.

MCDFX

China Dividend Fund
 

The Fund invests in companies that offer meaningful dividends yields, have sustainable business models and that demonstrate the propensity to pay increasing dividends over time.

LATEST SINOLOGY EDITIONS

Sinology

China Numbers that Count

Andy Rothman reviews data points that offer insights into the coming quarters.

01/25/2024

Video

Will Patience Be Rewarded in 2024?

Andy Rothman shares his insights on what Beijing may do to restore confidence in its economic policies.

12/21/2023

Sinology

Beijing Tests Our Patience

Will Beijing take the necessary steps to restore confidence in its economic policies? Sinology explores.

12/15/2023
View Sinology Archives

 

IMPORTANT INFORMATION

Investments involve risk. Past performance is no guarantee of future results. Investing in China may involve additional risks, such as social and political instability, market illiquidity, exchange-rate fluctuations, a high level of volatility and limited regulation. This material is provided for informational purposes only and should not be construed as investment advice or an offer to buy, sell, or hold any securities. The information contained herein has been derived from sources believed to be reliable and accurate at the time of compilation, but no representation or warranty (express or implied) is made as to the accuracy or completeness of any of this information. Matthews Asia and its affiliates do not accept any liability for losses either direct or consequential caused by the use of this information. The views and opinions expressed herein are as of the date of publication, are subject to change and may not reflect current views or opinions.